Professor Asif Ahmed
Non-Executive Director
Full title
Non-Executive Director & Member of Investment Committee
Biography
Professor Asif Ahmed is a globally acclaimed entrepreneurial scientist committed to eradicating pre-eclampsia through groundbreaking innovations. He discovered protective pathways to prevent pre-eclampsia and founded Aston Medical School (AMS), Birmingham’s first new medical school in 200 years, renowned for producing graduates who remain in the NHS. Professor Ahmed holds degrees from King’s College London and University College London, with research stints at the University of Cambridge, the University of Birmingham, and Stanford University.
He now leads MirZyme Therapeutics, a biopharmaceutical company with the mission: “one test, one pill, saving two lives.” MirZyme’s flagship innovations, M-PREG® (a digital diagnostic portal) and MZe786 (an oral treatment), address global pregnancy complications, with regulatory approvals and clinical advancements underway. Backed by over $40 million in research funding, ten global patents, and MHRA Innovation Passport approval, MirZyme has transitioned to development, attracting late-stage investors and big pharmaceutical interest.
Accolades like the Lee Kuan Yew Global Business Plan Competition’s “Best Professor-Student Prize” and the UK Government’s Female Founder Cohort Award affirm MirZyme’s high-growth potential and commitment to global health.